Goto

Collaborating Authors

Canadian Agritech Startup Farmers Edge Inc. Files IPO to Raise CAD 100 Million

#artificialintelligence

Farmers Edge Inc, an AI startup to help growers increase crop yields, plans to go public on Canada's largest Toronto Stock Exchange under the ticker symbol "FDGE". The company seeks to raise CAD 100 million (approximately USD 79 million). Founded in 2005, Farmers Edge uses AI technology to collect and analyze local weather, soil moisture and satellite data to help farmers improve crop efficiency and yield. Besides the Canadian Prairie, the company currently hosts offices in the United States, Australia, Russia, Brazil and Ukraine. As of the end of 2020, more than 3,000 growers have used the Farmers Edge products, covering more than 23 million acres of land in six countries.


Deep Learning Chip Market Breaking New Grounds and Touch New Level in upcoming year by

#artificialintelligence

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.


Big Data & Machine Learning in Telecom Market Breaking New Grounds and Touch New Level in upcoming year by

#artificialintelligence

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.


Global Lega-Tech Artificial Intelligence Market Economic Outlook, Market Structure Analysis,Forecast from 2021-2025 – NeighborWebSJ

#artificialintelligence

The information presented in Lega-Tech Artificial Intelligence Market Report 2021 includes qualitative and quantitative insights. Under the qualitative analysis part, manufacturing base, raw materials data, Lega-Tech Artificial Intelligence status, trends, SWOT analysis, PESTEL Analysis, distribution channels, driving factors, and a competitive structure is presented. Under the qualitative analysis part, market value/volume, production analysis, consumption data, import-export data, or each region and country are explained. Also, industry size by Lega-Tech Artificial Intelligence type, application, demand and supply scenario, and economic status are explained. Also, comprehensive information on the latest product development, growth opportunities, industry strategies, cost structures, and recent policies are enlightened in the Lega-Tech Artificial Intelligence report.


Microdosing's Feel-Good Benefits Might Just Be Placebo Effect

WIRED

In 2018, volunteers with an interest in microdosing--regularly taking tiny amounts of psychedelic drugs such as LSD--began taking part in an unusual experiment. For four weeks, researchers at Imperial College London asked them to swap some of their drugs with empty capsules--placebos--so that when they took them, they didn't know if they were microdosing or not. They then completed online surveys and cognitive tasks at regular intervals, aimed at gauging their mental well-being and cognitive abilities. The idea: to explore if microdosing produces the benefits to mood and brain function that some people claim. This story originally appeared on WIRED UK.


Latest 2021 Stanford AI Study Gives Deep Look into the State of the Global AI Marketplace

#artificialintelligence

Despite major disruptions from the ongoing COVID-19 pandemic, global investment in AI technologies grew by 40 percent in 2020 to $67.9 billion, up from $48.8 billion in 2019, as AI research and use continues to boom across broad segments of bioscience, healthcare, manufacturing and more. The figures, compiled as part of Stanford University's Artificlal Intelligence Index Report 2021 on the state of AI research, development, implementation and use around the world, help illustrate the continually changing scope of the still-maturing technology. The 222-page AI Index 2021 report, touted as the school's fourth annual study of AI impact and progress, was released March 3 by Stanford's Institute for Human-Centered Artificial Intelligence. The report provides a detailed portrait of the AI waterfront last year, including increasing AI investments and use in medicine and healthcare, China's growth in AI research, huge gains in AI capabilities across industries, concerns about diversity among AI researchers, ongoing debates about AI ethics and more. "The impact of AI this past year was both societal and economic, driven by the increasingly rapid progress of the technology itself," AI Index co-chair Jack Clark said in a statement.


Anghami goes public on NASDAQ via SPAC

#artificialintelligence

Anghami offers more than 57 million Arabic and international songs to more than 70 million of its registered users, with around one billion streams per month. With an Arabic speaking population of over 450 million globally, its listing on NASDAQ allows Anghami to scale its user base and invest in technology to build on its data play. Anghami's AI and machine learning algorithms process over 56 million data points from its user base every day. Over nine years of user data is enabling the company to predict user behaviour and trends to better focus its investments and improve monetization.


AI reveals current drugs that may help combat Alzheimer's

#artificialintelligence

New York, March 7 (IANS) Researchers have developed a method based on Artificial Intelligence (AI) that rapidly identifies currently available medications that may treat Alzheimer's disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. Importantly, it could also help reveal new, unexplored targets for therapy by pointing to mechanisms of drug action. "Repurposing FDA-approved drugs for Alzheimer's disease is an attractive idea that can help accelerate the arrival of effective treatment -- but unfortunately, even for previously approved drugs, clinical trials require substantial resources, making it impossible to evaluate every drug in patients with Alzheimer's disease," said researcher Artem Sokolov from Harvard Medical School. "We therefore built a framework for prioritising drugs, helping clinical studies to focus on the most promising ones," Sokolov added.


BIS reports on Big Data and machine learning in central banking

#artificialintelligence

The world is changing and so is the way it is measured. For decades, policymakers and the private sector have relied on data released by official statistical institutions to assess the state of the economy.


Deep Dive Into Neural Networks

#artificialintelligence

Apart from well-known Applications like image and voice recognition Neural Networks are being used in several contexts to find complex patterns among very large data sets, an example is when an E-mail engine is suggesting sentence completion or when a machine translating one language to another. For solving such complex problems we use Artificial Neural Network. An Artificial Neural Network(ANN) is often called a black box technique because it can be sometimes hard to understand what they are doing. It is a sequence of mathematical calculations which are best visualized through neural networks. ANN is vaguely inspired by Biological Neural Network that constitutes the human brain.